Why Uttarakhand
SIDCUL Bahadrabad offers established pharma infrastructure, skilled workforce and connectivity to North India distribution networks.
Manufacturing Locations
Two units — Haridwar (Uttarakhand) and Kathua (J&K) — ₹125 crore combined investment.
Unit-1
Near Indane Gas Plant,
Industrial Area, Bahadrabad,
Haridwar — 249402,
Uttarakhand, India
Haridwar — SIDCUL Bahadrabad
Flagship WHO-GMP certified facility with dedicated beta-lactam, cephalosporin and general formulation blocks. License obtained November 2023.
Sucantis Biotech Private Limited
Plot No. E-127 & 128, SIDCUL,Near Indane Gas Plant,
Industrial Area, Bahadrabad,
Haridwar — 249402,
Uttarakhand, India
- Beta-lactam, cephalosporin & general blocks
- Tablets, capsules & dry syrup lines
- Export neutral code for international supply
- Plant visits by prior appointment
Unit-2
Kathua, Jammu & Kashmir
Second manufacturing unit to expand beta-lactam and cephalosporin capacity. License obtained May 2025.
Unit-2 — Kathua, J&K
License May 2025 · Scaling commercial productionStrategic expansion supporting growing domestic CDMO demand and export programmes for beta-lactam and cephalosporin formulations.
- Dedicated beta-lactam & cephalosporin manufacturing
- Quality systems aligned with Unit-1 standards
- Head Quality — Mr. Hitender Verma (20+ years, USFDA/MHRA/EU/WHO)
Dual-unit strategy
Haridwar and Kathua provide redundant capacity and geographic flexibility for domestic and export supply programmes.
Visitor guidance
Plant visits for serious manufacturing partners. Write to info@sucantis.com with preferred dates.
Plan a visit or logistics discussion
Our team will coordinate directions, visit slots and commercial enquiries.
Contact Us